CNBC Business
•
11/04/2025
•
Free
Kimberly-Clark’s recent $48.7 billion deal to acquire Kenvue highlights a major strategic investment aimed at expanding its market presence and levera...
Read Full Article →
Investopedia
•
11/03/2025
•
Free
The recent market activity highlights notable shifts as Amazon's shares rose following a collaboration with OpenAI, while Kimberly-Clark expanded its...
Read Full Article →
Economic Times Markets
•
11/03/2025
•
Subscription Required
Major technology companies' collaboration and significant acquisition activities contributed to a positive start in US markets, reflecting investor co...
Read Full Article →
Investopedia
•
11/03/2025
•
Free
Several major companies, including Amazon, Kenvue, Kimberly-Clark, and Beyond Meat, experienced notable shifts in their stock prices, reflecting chang...
Read Full Article →
Investopedia
•
11/03/2025
•
Free
The recent market movements reflect a shift in investor focus, with technology sector advancements influencing equity prices while corporate acquisiti...
Read Full Article →
Financial Times
•
11/03/2025
•
Subscription Required
The $49 billion agreement between Kimberly-Clark and Kenvue represents a major financial transaction amid a surge of mergers and acquisitions througho...
Read Full Article →
The Guardian – Business
•
11/03/2025
•
Free
Kimberly-Clark’s proposed acquisition of Kenvue, the consumer health division formerly part of Johnson & Johnson, represents a significant transaction...
Read Full Article →
The Guardian – Business
•
10/28/2025
•
Free
The lawsuit may lead to significant financial liabilities for the companies involved, potentially affecting their market value and resulting in costly...
Read Full Article →
Investopedia
•
10/17/2025
•
Free
Several prominent companies, including Kenvue, American Express, Truist, and Newmont, are experiencing notable fluctuations in their share prices, ref...
Read Full Article →
Investopedia
•
09/23/2025
•
Free
Following claims associating a popular pain reliever with autism, the company’s shares recovered previous declines, reflecting market adjustments to e...
Read Full Article →
Globe and Mail Investing
•
09/23/2025
•
Subscription Required
Kenvue's stock recovery reflects investor confidence despite ongoing skepticism in the medical community, though analysts caution that persistent nega...
Read Full Article →
Quartz
•
09/23/2025
•
Limited Free
Following unsubstantiated claims linking a common pain reliever to developmental issues, investor confidence in Kenvue increased, leading to a notable...
Read Full Article →
MarketWatch Top Stories
•
09/23/2025
•
Limited Free
Kenvue's shares experienced a notable recovery following a press briefing that failed to present new information potentially increasing legal risks re...
Read Full Article →
MarketWatch Top Stories
•
09/22/2025
•
Limited Free
Kenvue’s stock declined sharply following public statements linking its acetaminophen product to developmental concerns, raising investor uncertainty...
Read Full Article →
Investopedia
•
09/22/2025
•
Free
Shares of Kenvue declined as investors reacted to potential regulatory and legal challenges stemming from claims linking prenatal Tylenol use to autis...
Read Full Article →
Investopedia
•
09/22/2025
•
Free
Shares of major technology companies experienced mixed movements today, with Oracle and Nvidia showing positive performance while Kenvue's stock decli...
Read Full Article →
Investopedia
•
09/22/2025
•
Free
Nvidia, Apple, Kenvue, and several other companies experienced notable changes in their stock prices, reflecting shifts in market sentiment and potent...
Read Full Article →
Financial Times
•
09/22/2025
•
Subscription Required
The announcement about potential health concerns involving a popular over-the-counter medication has caused a notable decline in Kenvue’s stock value...
Read Full Article →
Investopedia
•
09/22/2025
•
Free
The report suggesting a potential connection between Tylenol and autism has caused a decline in Kenvue’s stock value, reflecting investor concerns abo...
Read Full Article →
MarketWatch Top Stories
•
09/05/2025
•
Limited Free
Kenvue’s efforts to address safety allegations related to a popular product coincided with a significant decline in its share value, reflecting invest...
Read Full Article →
Investopedia
•
09/05/2025
•
Free
Shares of the pharmaceutical company experienced a decline after news emerged that a prominent figure plans to associate the product with autism, pote...
Read Full Article →
CNBC Business
•
09/05/2025
•
Free
The anticipated government report suggesting a connection between prenatal Tylenol use and autism has led to a notable decline in Kenvue’s market valu...
Read Full Article →
Investopedia
•
07/14/2025
•
Free
The departure of Kenvue’s CEO during a strategic evaluation may influence investor confidence and affect the company’s market performance and financia...
Read Full Article →
Investopedia
•
06/03/2025
•
Free
Kenvue experienced a notable drop in its stock value, reflecting concerns expressed by the CEO regarding reduced consumer demand typically observed du...
Read Full Article →
